• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Clinical Profile of SARS-CoV-2-Infected Neonates

tetano

Editor, Senior Moderator
Cureus


. 2022 Jun 24;14(6):e26298.
doi: 10.7759/cureus.26298. eCollection 2022 Jun.
Clinical Profile of SARS-CoV-2-Infected Neonates


Rajesh K Kulkarni[SUP] 1 [/SUP], Chhaya Valvi[SUP] 2 [/SUP], Rahul Dawre[SUP] 2 [/SUP], Uday Rajput[SUP] 2 [/SUP], Rema Nagpal[SUP] 3 [/SUP], Isha Deshmukh[SUP] 2 [/SUP], Pragathi Kamath[SUP] 2 [/SUP], Richa Harwani[SUP] 2 [/SUP], Ramya Srinivasarangan[SUP] 2 [/SUP], Somendra Sonteke[SUP] 2 [/SUP], Apoorva R[SUP] 2 [/SUP], Savita Kamble[SUP] 4 [/SUP], Shilpa Naik[SUP] 4 [/SUP], Ramesh Bhosale[SUP] 4 [/SUP], Rakeesh Waghmare[SUP] 5 [/SUP], Deepak Modi[SUP] 6 [/SUP], Rahul Gajbhiye[SUP] 7 [/SUP], Aarti A Kinikar[SUP] 2 [/SUP]



Affiliations

Abstract

Background There are conflicting data on the mother-to-child transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and few studies have described the clinical course of neonates infected with SARS-CoV-2. Objectives This study investigates the mother-to-child transmission rate and clinical profile of SARS-CoV-2-infected newborns. Methods Data on 304 newborns of 301 mothers with coronavirus disease 2019 (COVID-19) were prospectively collected and analyzed. Reverse transcription-polymerase chain reaction (RT-PCR) determined the presence of SARS-CoV-2 in the placenta, umbilical cord stump, and nasopharyngeal swabs collected within 24h of birth. Clinical and laboratory data of SARS-CoV-2-infected newborns was entered in a structured proforma. Results A total of 20 neonates (6.5%) were positive for SARS-CoV-2, of which 12 were positive only in the nasopharyngeal swab, four cases had the umbilical stump positive, three were positive in the placenta, and one case was positive in all the three specimens collected. Six of the 20 SARS-CoV-2-positive neonates developed severe symptoms. The SARS-CoV-2-positive symptomatic neonates required a more extended stay in hospital compared to their non-symptomatic infected counterparts. Conclusions A proportion of the babies born to SARS-CoV2-infected mothers tested positive and some of these newborns had severe symptoms.

Keywords: clinical profile; inflammation; mother to child transmission; newborn; sars-cov-2.
 
Back
Top Bottom